FR2206947A1 - - Google Patents

Info

Publication number
FR2206947A1
FR2206947A1 FR7341140A FR7341140A FR2206947A1 FR 2206947 A1 FR2206947 A1 FR 2206947A1 FR 7341140 A FR7341140 A FR 7341140A FR 7341140 A FR7341140 A FR 7341140A FR 2206947 A1 FR2206947 A1 FR 2206947A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7341140A
Other languages
French (fr)
Other versions
FR2206947B1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Publication of FR2206947A1 publication Critical patent/FR2206947A1/fr
Application granted granted Critical
Publication of FR2206947B1 publication Critical patent/FR2206947B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7341140A 1972-11-20 1973-11-19 Expired FR2206947B1 (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5343772A GB1408010A (en) 1972-11-20 1972-11-20 Sulphamoylphenyl-imidazolidinones

Publications (2)

Publication Number Publication Date
FR2206947A1 true FR2206947A1 (OSRAM) 1974-06-14
FR2206947B1 FR2206947B1 (OSRAM) 1977-10-28

Family

ID=10467808

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7341140A Expired FR2206947B1 (OSRAM) 1972-11-20 1973-11-19

Country Status (21)

Country Link
US (1) US3963706A (OSRAM)
JP (1) JPS541312B2 (OSRAM)
AR (1) AR211379Q (OSRAM)
AT (1) AT330766B (OSRAM)
AU (1) AU470359B2 (OSRAM)
BE (1) BE807490A (OSRAM)
CA (1) CA1021783A (OSRAM)
CH (3) CH605802A5 (OSRAM)
DE (1) DE2357591C3 (OSRAM)
DK (1) DK138645B (OSRAM)
ES (1) ES420661A1 (OSRAM)
FI (1) FI57934C (OSRAM)
FR (1) FR2206947B1 (OSRAM)
GB (1) GB1408010A (OSRAM)
HU (1) HU170143B (OSRAM)
IE (1) IE39319B1 (OSRAM)
IL (1) IL43652A (OSRAM)
NL (1) NL7315807A (OSRAM)
PL (1) PL97758B1 (OSRAM)
SE (1) SE417960B (OSRAM)
ZA (1) ZA738824B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
JP2003515558A (ja) * 1999-12-06 2003-05-07 ロード アイランド ホスピタル, ア ライフスパン パートナー 腫瘍を治療するためのメチロール含有化合物の使用
YU52403A (sh) 2000-12-26 2006-03-03 Dr.Reddy's Research Foundation Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
US7160912B2 (en) 2000-12-26 2007-01-09 Dr.Reddy's Laboratories Ltd. Heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
WO2003028642A2 (en) 2001-10-01 2003-04-10 Rhode Island Hospital, A Lifespan Partner Methods of inhibiting metastases
US20070004712A1 (en) * 2001-12-21 2007-01-04 Dr. Reddy's Laboratories Ltd. Salts of novel heterocyclic compounds having antibacterial activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1472625A (OSRAM) * 1965-03-31 1967-05-24

Also Published As

Publication number Publication date
PL97758B1 (pl) 1978-03-30
FR2206947B1 (OSRAM) 1977-10-28
JPS4993362A (OSRAM) 1974-09-05
DE2357591A1 (de) 1974-05-22
DK138645C (OSRAM) 1979-03-19
FI57934B (fi) 1980-07-31
SE417960B (sv) 1981-04-27
GB1408010A (en) 1975-10-01
AU470359B2 (en) 1975-05-22
ZA738824B (en) 1974-09-25
IE39319L (en) 1974-05-20
CH605808A5 (OSRAM) 1978-10-13
DK138645B (da) 1978-10-09
CA1021783A (en) 1977-11-29
NL7315807A (OSRAM) 1974-05-22
ATA968773A (de) 1975-10-15
BE807490A (fr) 1974-05-20
AU6266073A (en) 1975-05-22
DE2357591C3 (de) 1980-02-28
US3963706A (en) 1976-06-15
AT330766B (de) 1976-07-26
CH603594A5 (OSRAM) 1978-08-31
ES420661A1 (es) 1976-04-01
IL43652A0 (en) 1974-03-14
CH605802A5 (OSRAM) 1978-10-13
FI57934C (fi) 1980-11-10
AR211379Q (es) 1977-12-15
IL43652A (en) 1977-10-31
HU170143B (OSRAM) 1977-04-28
DE2357591B2 (de) 1979-07-05
IE39319B1 (en) 1978-09-13
JPS541312B2 (OSRAM) 1979-01-23

Similar Documents

Publication Publication Date Title
IN139063B (OSRAM)
DK138645C (OSRAM)
CS156922B1 (OSRAM)
JPS5232541Y2 (OSRAM)
JPS4954951U (OSRAM)
JPS4927671A (OSRAM)
JPS555521Y2 (OSRAM)
JPS496169A (OSRAM)
CS154024B1 (OSRAM)
JPS4974100A (OSRAM)
CS153919B1 (OSRAM)
CS154090B1 (OSRAM)
CS156805B1 (OSRAM)
CS156136B1 (OSRAM)
JPS4894383U (OSRAM)
CH573498A5 (OSRAM)
CH569204A5 (OSRAM)
CH592161A5 (OSRAM)
CH563039A5 (OSRAM)
CH574977A5 (OSRAM)
CH571105B5 (OSRAM)
CH568085A5 (OSRAM)
BG18223A1 (OSRAM)
CH569955A5 (OSRAM)
BG17922A1 (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse